ÀÖ²¥´«Ã½app×îа汾

In 2025, Moderna spent 797 million U.S. dollars on Shared discovery and development expenses as part of its research and development expenses. Moderna became well-known for its COVID-19 vaccine Spikevax (mRNA-1273), one of the very first vaccines to be developed and approved for widespread use.